Ortho Biotech, Curis Aim For BMP-7 To Prevent Need For Kidney Dialysis
This article was originally published in The Gray Sheet
Executive Summary
Johnson & Johnson's Ortho Biotech unit plans to file an investigational new drug application in mid-2004 for use of recombinant bone morphogenic protein-7 to treat kidney dialysis patients